All In Biotech

Free tool

FAERS Monitor: Rapamune

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021083 or its brand name (Rapamune, Sirolimus). Reports on generic versions are filed under their own applications.

Reports

13,477

Serious

11,670

87% of reports

Hospitalization

4,673

Death reported

2,174

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use2,076
  • drug ineffective1,139
  • product use in unapproved indication786
  • pyrexia531
  • diarrhoea529
  • pneumonia500
  • drug interaction450
  • acute kidney injury443
  • thrombotic microangiopathy386
  • transplant rejection384
  • cytomegalovirus infection355
  • condition aggravated317
  • nausea317
  • toxicity to various agents316
  • infection312

Reports by year received

View as table
YearReports
200441
200553
200651
2007232
2008194
2009294
2010152
2011253
2012231
2013204
2014239
2015315
2016425
2017598
2018845
2019990
20201,021
20211,054
20221,230
20231,128
20241,437
20251,502
2026988

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,682 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
transplant rejectionSignal38478.570.927,908
thrombotic microangiopathySignal38664.358.223,060
cytomegalovirus infectionSignal35534.030.711,118
product use in unapproved indicationSignal7865.04.62,504
acute kidney injurySignal4434.54.11,220
drug interactionSignal4504.44.11,200
off label useSignal2,0763.73.64,268
infectionSignal3123.43.0520
toxicity to various agentsSignal3162.92.6402
pneumoniaSignal5002.42.2418
pyrexiaSignal5312.42.2438
condition aggravated3171.61.577
drug ineffective1,1391.31.3109
diarrhoea5291.31.233
nausea3170.60.674

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.